<VariationArchive VariationID="3552" VariationName="NM_001042432.2(CLN3):c.461-280_677+382del" VariationType="Deletion" Accession="VCV000003552" Version="8" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-08" DateCreated="2013-04-04" MostRecentSubmission="2023-09-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18591" VariationID="3552">
      <GeneList>
        <Gene Symbol="CLN3" FullName="CLN3 lysosomal/endosomal transmembrane protein, battenin" GeneID="1201" HGNC_ID="HGNC:2074" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="28466653" stop="28492082" display_start="28466653" display_stop="28492082" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="28488599" stop="28503622" display_start="28488599" display_stop="28503622" Strand="-" />
          </Location>
          <OMIM>607042</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001042432.2(CLN3):c.461-280_677+382del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="28485965" stop="28486930" display_start="28485965" display_stop="28486930" variantLength="966" positionVCF="28485964" referenceAlleleVCF="GATTGCAATCATAATCAAGTTTTCTTTTCTTTCTTTTTTTTTTTTTCTTCCTGAGACAGAGTCTAACTCTGTCGCCCGGGCTGGAGTGCAATGGCACGATCTCGGCTCACTGCCACCACTGCCTCCGGGGTTCAAGCGATTCTCCTGCCTTAGCCTCCTGAGTAGTTGGGACTACAGGCACCCGCCACCACACCTGGCTAATTGTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTGGCCAGGCTGGTTTCCTGACCTTAGGCGATCTGCCCTCCTTGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCACACCCAGCCATGGCCAAGTTTTCTCTCCTTGGACCCCTCTCCCTCCCGGCTCAGGGCAGCTCACCTGGCCAGCAGCAGGGCAGGGATACCCAGCATGGACAGCAGGGTCTGCTGAGGGGAGAGGCCGGCCTGGGTGAGGCCCAGGTAGGACAGGGCCCCCAGCAGCCCAGCTCCCCCAGTCCCTGAGGACCACCAGGAGATCACGGCCCTGGGAAGGAGAACACAGGAACATTCAGGAGGACCTAGGCTGACCATGGGACAGCCTCTCCCCACACTCCCTGCTCCACCTGCTTACCTGGGGTAGAAGGCAGTGAGGGAGAGGAAGGTGACCTCCCCAAGGCCTGATGAGATGCTAGCGAAGACCACACCTGGGGGGAGGACAAGCACTGGGATGGTCACACCACACCTTGCCACACTGCCCAGGCCTCTAATGTGTCTGGCCATGGCCTCCTCAGTATCAGCTCATAGAGGCTCCAATAGATCCCATGCATAGGCCAGGTTCCAGGTCTGAAGCAGAGCCCCACTCCCCTGCGTGTCCCTTCATGGAGAGTGGCACCTCCATCCACCCAGTTATCAGACCAGGGGCAGACATGCACCCTTGATGTCTCTGCCCCTTCATCAGTCTTTTTCTTTTCTTTTCTTTTTGGA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="28497286" stop="28498251" display_start="28497286" display_stop="28498251" variantLength="966" positionVCF="28497285" referenceAlleleVCF="GATTGCAATCATAATCAAGTTTTCTTTTCTTTCTTTTTTTTTTTTTCTTCCTGAGACAGAGTCTAACTCTGTCGCCCGGGCTGGAGTGCAATGGCACGATCTCGGCTCACTGCCACCACTGCCTCCGGGGTTCAAGCGATTCTCCTGCCTTAGCCTCCTGAGTAGTTGGGACTACAGGCACCCGCCACCACACCTGGCTAATTGTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTGGCCAGGCTGGTTTCCTGACCTTAGGCGATCTGCCCTCCTTGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCACACCCAGCCATGGCCAAGTTTTCTCTCCTTGGACCCCTCTCCCTCCCGGCTCAGGGCAGCTCACCTGGCCAGCAGCAGGGCAGGGATACCCAGCATGGACAGCAGGGTCTGCTGAGGGGAGAGGCCGGCCTGGGTGAGGCCCAGGTAGGACAGGGCCCCCAGCAGCCCAGCTCCCCCAGTCCCTGAGGACCACCAGGAGATCACGGCCCTGGGAAGGAGAACACAGGAACATTCAGGAGGACCTAGGCTGACCATGGGACAGCCTCTCCCCACACTCCCTGCTCCACCTGCTTACCTGGGGTAGAAGGCAGTGAGGGAGAGGAAGGTGACCTCCCCAAGGCCTGATGAGATGCTAGCGAAGACCACACCTGGGGGGAGGACAAGCACTGGGATGGTCACACCACACCTTGCCACACTGCCCAGGCCTCTAATGTGTCTGGCCATGGCCTCCTCAGTATCAGCTCATAGAGGCTCCAATAGATCCCATGCATAGGCCAGGTTCCAGGTCTGAAGCAGAGCCCCACTCCCCTGCGTGTCCCTTCATGGAGAGTGGCACCTCCATCCACCCAGTTATCAGACCAGGGGCAGACATGCACCCTTGATGTCTCTGCCCCTTCATCAGTCTTTTTCTTTTCTTTTCTTTTTGGA" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>NC_000016.9:g.28497286_28498251del</Name>
        <Name>NP_001035897.1:p.(Gly154Alafs*29)</Name>
        <Name>1.02-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.28485965_28486930del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.28485965_28486930del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.28497286_28498251del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.28497286_28498251del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008654.2" sequenceAccession="NG_008654" sequenceVersion="2" change="g.10373_11338del">
            <Expression>NG_008654.2:g.10373_11338del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001286109.2" sequenceAccession="NM_001286109" sequenceVersion="2" change="c.227-280_443+382del">
            <Expression>NM_001286109.2:c.227-280_443+382del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001286104.2" sequenceAccession="NM_001286104" sequenceVersion="2" change="c.389-280_605+382del">
            <Expression>NM_001286104.2:c.389-280_605+382del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001286105.2" sequenceAccession="NM_001286105" sequenceVersion="2" change="c.161-280_377+382del">
            <Expression>NM_001286105.2:c.161-280_377+382del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001286110.2" sequenceAccession="NM_001286110" sequenceVersion="2" change="c.299-280_515+382del">
            <Expression>NM_001286110.2:c.299-280_515+382del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000086.2" sequenceAccession="NM_000086" sequenceVersion="2" change="c.461-280_677+382del">
            <Expression>NM_000086.2:c.461-280_677+382del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042432.2" sequenceAccession="NM_001042432" sequenceVersion="2" change="c.461-280_677+382del" MANESelect="true">
            <Expression>NM_001042432.2:c.461-280_677+382del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_689" sequenceAccession="LRG_689">
            <Expression>LRG_689:g.10373_11338del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_689t1" sequenceAccession="LRG_689t1">
            <Expression>LRG_689t1:c.461-280_677+382del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_689t2" sequenceAccession="LRG_689t2">
            <Expression>LRG_689t2:c.461-280_677+382del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340096" DB="ClinGen" />
        <XRef ID="nssv3761552" DB="dbVar" />
        <XRef ID="nsv1067855" DB="dbVar" />
        <XRef Type="Allelic variant" ID="607042.0001" DB="OMIM" />
        <XRef Type="rs" ID="1555468634" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">1.02-kb deletion in CLN3.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001042432.2(CLN3):c.461-280_677+382del AND Neuronal ceroid lipofuscinosis 3" Accession="RCV000003731" Version="5">
        <ClassifiedConditionList TraitSetID="926">
          <ClassifiedCondition DB="MedGen" ID="C0751383">Neuronal ceroid lipofuscinosis 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-01-15" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001042432.2(CLN3):c.461-280_677+382del AND not provided" Accession="RCV000724164" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-02-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001042432.2(CLN3):c.461-280_677+382del AND Retinitis pigmentosa" Accession="RCV003324482" Version="2">
        <ClassifiedConditionList TraitSetID="6496">
          <ClassifiedCondition DB="MedGen" ID="C0035334">Retinitis pigmentosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-24" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2013-04-04" MostRecentSubmission="2023-09-03">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17947292</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">36909829</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7553855</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9004140</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9311735</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9392580</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CLN3</URL>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301601</ID>
          <ID Source="BookShelf">NBK1428</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="926" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="768" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spielmeyer Sjogren disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis 3</ElementValue>
                <XRef ID="MONDO:0008767" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CLN3-Related Neuronal Ceroid-Lipofuscinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CLN3 Disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CLN3</ElementValue>
                <XRef Type="MIM" ID="204200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Batten Disease</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5897" />
                <XRef ID="5897" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="228346" DB="Orphanet" />
              <XRef ID="C0751383" DB="MedGen" />
              <XRef ID="MONDO:0008767" DB="MONDO" />
              <XRef Type="MIM" ID="204200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6496" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9558" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tapetoretinal degeneration</ElementValue>
                <XRef ID="HP:0000547" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Retinitis pigmentosa</ElementValue>
                <XRef ID="CN038210" DB="ADAM" />
                <XRef ID="Retinitis+pigmentosa/6248" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019200" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS268000" DB="OMIM" />
                <XRef ID="28835009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RP</ElementValue>
                <XRef Type="MIM" ID="268000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Autosomal dominant, autosomal recessive and X linked inheritance</Attribute>
                <XRef ID="GTR000561973" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5694" />
                <XRef ID="5694" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301590</ID>
                <ID Source="BookShelf">NBK1417</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2012">
                <ID Source="PubMed">22234150</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Bakondi et al., 2015">
                <ID Source="PubMed">26666451</ID>
              </Citation>
              <XRef ID="791" DB="Orphanet" />
              <XRef ID="C0035334" DB="MedGen" />
              <XRef ID="D012174" DB="MeSH" />
              <XRef ID="MONDO:0019200" DB="MONDO" />
              <XRef Type="MIM" ID="268000" DB="OMIM" />
              <XRef Type="Phenotypic series" ID="PS268000" DB="OMIM" />
              <XRef Type="secondary" ID="HP:0000547" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1373136" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2013-10-08">
        <ClinVarSubmissionID localKey="22046_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000700734" DateUpdated="2018-12-15" DateCreated="2013-10-08" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-02-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLN3" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="-" referenceAllele="-" start="28497286" stop="28498251" variantLength="966" />
            <GeneLocation>NM_001042432.1:IVS7</GeneLocation>
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CLN3</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="23894" SubmissionDate="2020-03-20" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607042.0001_CEROID LIPOFUSCINOSIS, NEURONAL, 3" title="CLN3, 1.02-KB DEL_CEROID LIPOFUSCINOSIS, NEURONAL, 3" />
        <ClinVarAccession Accession="SCV000023894" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-01-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">The International Batten Disease Consortium (1995) demonstrated that the mutation responsible for 73% of Batten disease (CLN3; 204200) chromosomes as identified by the 56 haplotype is a genomic deletion of 1.02 kb, including 217 bp of the open reading frame (nucleotides 598-814), corresponding to 2 exons. Deletion of these 217 bp of coding sequence produces a frameshift, generating a TAA termination codon 84 bp downstream of the deletion junction. The predicted translation product is a truncated protein of 181 amino acids consisting of the first 153 residues of the protein, followed by 28 novel amino acids before the stop codon.</Attribute>
              <Citation>
                <ID Source="PubMed">7553855</ID>
              </Citation>
              <XRef DB="OMIM" ID="204200" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In Finland, 90% of patients with Batten disease carry the 1.02-kb deletion. Jarvela et al. (1996) developed a rapid diagnostic solid-phase minisequencing test to detect this deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">9004140</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">This 1.02-kb deletion in homozygous form always causes a severe phenotype, including blindness, epilepsy, dementia, and early death at approximately 24 years of age (Munroe et al., 1997; Jarvela et al., 1997).</Attribute>
              <Citation>
                <CitationText>Munroe, P. B., Mitchison, H. M., O'Rawe, A. M., Anderson, J. W., Boustany, R.-M., Lerner, T. J., Taschner, P. E. M., de Vos, N., Breuning, M. H., Gardiner, R. M., Mole, S. E. Spectrum of mutations in the Batten disease gene, CLN3. Am. J. Hum. Genet. 61: 310-316, 1997.</CitationText>
              </Citation>
              <Citation>
                <ID Source="PubMed">9392580</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Kitzmuller et al. (2008) demonstrated that the common 1.02-kb deletion retains residual function. Two mutant CLN3 transcripts were present in patient cells homozygous for the mutation: the major transcript encoded a truncated protein encoding residues 1 through 153 followed by 28 additional amino acids, and the minor transcript encoded a protein that spliced exon 6 to exon 10 with restoration of the reading frame after exon 10. When RNA silencing was used to deplete these transcripts in patients' cells, the lysosomes significantly increased in size, confirming that the protein was functional. Overexpression of mutant CLN3 transcript consistently caused lysosomes to decrease in size. Studies in mouse cell models and yeast confirmed that the corresponding mutant transcripts retained significant function. The majority of the mutant 1.02-kb deletion CLN3 protein was retained within the endoplasmic reticulum. Kitzmuller et al. (2008) concluded that the common mutant CLN3 protein retains significant function and that JNCL is a mutation-specific disease phenotype. The residual function likely explains why this form of CLN shows later onset and less severe clinical manifestations compared to other forms of CLN.</Attribute>
              <Citation>
                <ID Source="PubMed">17947292</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLN3" />
          </GeneList>
          <Name>CLN3, 1.02-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1.02-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607042.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CEROID LIPOFUSCINOSIS, NEURONAL, 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="145566" SubmissionDate="2013-04-30" DateLastUpdated="2022-10-01" DateCreated="2013-10-01">
        <ClinVarSubmissionID localKey="NM_001042432.1:c.461-280_677+382del_NBK1428" title="NM_001042432.1:c.461-280_677+382del and Neuronal Ceroid-Lipofuscinoses" />
        <ClinVarAccession Accession="SCV000086830" DateUpdated="2022-10-01" DateCreated="2013-10-01" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">9311735</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">20301601</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="BookShelf">NBK1428</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001042432.1:c.461-280_677+382del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751383" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7540396" SubmissionDate="2023-07-26" DateLastUpdated="2023-09-03" DateCreated="2023-09-03">
        <ClinVarSubmissionID localKey="NM_001042432.2:c.461-280_677+382del|Retinitis pigmentosa" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004030380" DateUpdated="2023-09-03" DateCreated="2023-09-03" Type="SCV" Version="1" SubmitterName="Ophthalmic Genetics Group, Institute of Molecular and Clinical Ophthalmology Basel" OrgID="507918" OrganizationCategory="other" OrgAbbreviation="IOB" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">36909829</ID>
          </Citation>
          <Comment>Clinical significance based on ACMG v2.0</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Portugal</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLN3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_001035897.1:p.(Gly154Alafs*29)</Name>
            <Name>NC_000016.9:g.28497286_28498251del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001042432.2:c.461-280_677+382del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Retinitis pigmentosa</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment>This variant corresponds to the deletion of exons 5 and 6 in CLN3.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB13709878</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23894" TraitType="Disease" MappingType="Name" MappingValue="CEROID LIPOFUSCINOSIS, NEURONAL, 3" MappingRef="Preferred">
        <MedGen CUI="C0751383" Name="Neuronal ceroid lipofuscinosis 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="145566" TraitType="Disease" MappingType="XRef" MappingValue="C0751383" MappingRef="MedGen">
        <MedGen CUI="C0751383" Name="Neuronal ceroid lipofuscinosis 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1373136" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7540396" TraitType="Disease" MappingType="Name" MappingValue="Retinitis pigmentosa" MappingRef="Preferred">
        <MedGen CUI="C0035334" Name="Retinitis pigmentosa" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

